INTRODUCTION
============

Colorectal cancer is the most common type of gastrointestinal cancer. Its cause is multifactorial, including genetic, environmental exposure, diet, and inflammatory conditions of the digestive tract^[@r12]^. The incidence and mortality of it had a slight decrease over the past 20 years; however, colon cancer remained the third most common cause of cancer-related mortality in 2014^[@r02]^.In Brazil, 32,600 new cases were diagnosed in 2013 (15,070 male and 17 530 female)^[@r16]^.

There are many controversies in the literature about the prognostic value of tumor location^[@r23]^. Many studies have shown higher survival rates for tumors in the right colon, and worse prognosis as the lesions are located more distally^[@r09]^. The standard right colectomy for treatment of malignant tumors consists of en-block removal of the terminal ileum, cecum, ascending colon, hepatic flexure, proximal transverse colon, and their respective lymphovascular drainage and mesenteric lymph nodes. This includes resection of ileocolic and right colic vessels, and eventually the right branch of the middle colic vessels^[@r30]^.

The aim of this study was to analyze the results of surgical treatment of patients with right colon cancer stages I-IV operated in a period of ten years (2002-2012) and identify prognostic factors that were associated with lower overall survival.

METHODS
=======

In this series were evaluated the results of surgical treatment of patients with right colon cancer treated in the Service of Colon and Rectal Surgery of the Hospital das Clínicas, School of Medicine of University of São Paulo, São Paulo, Brazil, from 2002 - 2012. Data were collected retrospectively from prospectively collected database. Of 1219 patients treated, a total of 566 patients had colon cancer, and 199 (16.32%) were in the right colon. Of these, 187 underwent right hemicolectomy with curative intent thus making the total number of patients included in this study.

The following factors were studied: gender, age, tumor location, number of nodes removed in the specimen, lymph node status, T stage and presence of distant metastases. These factors were evaluated for the possibility of prognostic impact in five-year survival.

The bowel preparation was performed on the day before surgery. One liter of 10% mannitol solution was used for cases scheduled as open procedure, while 90 ml of sodium phosphate 10% solution was used for laparoscopic cases to prevent bowel gaseous distension. Intravenous antibiotic prophylaxis was performed 1 h before the start of operation with cephalosporin of second or third generation alone or combined with metronidazole, and maintained postoperatively for up to 36 h. The thromboembolic prophylaxis was made in all patients with subcutaneous enoxaparin injections.

The patient positioning on the operating table for either laparotomic or laparoscopic right colectomy was supine position with lower limbs opened. For laparoscopic procedures, patients were carefully set on the operating table with bandages and strips to allow intraoperative tilt, such as the Trendelenburg position and lateralization.

Surgical technique
------------------

According to oncologic principles, surgery included en-bloc resection, adequate lymphadenectomy, high ligation of vascular pedicle, and free resection margins. Surgical access was laparotomic or laparoscopic. High ligation of the ileocolyc and right colic vessels were done in all cases^[@r30]^. The right colon was mobilized by separating the terminal ileum and cecum of retroperitoneal structures such as the ureter, duodenum and gonadal vessels. At least 10 cm of terminal ileum was resected in all cases. Transverse colon was transected at least 5 cm distally to the primary tumor. When tumor was located in the proximal transverse colon, the right branch of the middle colic artery and vein were ligated. Gastrocolic ligament was sectioned and the transverse colon was completely mobilized in order to perform a tension free anastomosis with good blood supply. Ileocolic anastomosis was done manually (end-to-end) or mechanically or side-to-side.

Statistical analysis
--------------------

The SPSS software 20.0^®^ was used for the analyses of the variables. Patient and tumor characteristics were described with use of estimate measures (mean, standard deviation, and median, minimum and maximum) for quantitative variables. Absolute and relative frequencies were described for qualitative variables (Kirkwood and Sterne, 2006). Mean overall survival time was estimated according to the characteristics of interest using the Kaplan-Meier function (Kleinbaum, 1996); however, it was not possible to estimate the median time because the number of deaths was inferior to 50%. Survival rates between categories were compared using log-rank test (Kleinbaum, 1996). Hazard Ratios (HR) with 95% confidence intervals were estimated by bivariate Cox regression. Cox multiple regression analyses were used to simultaneously explore the effects of several variables on overall survival (Kleinbaum, 1996). Two models were created: one considering stage T, N and M separately, and other model considering the final stage (TNM) of the tumor. The tests were performed at a significance level of 5%.

RESULTS
=======

A total of 187 patients underwent right colectomy. Women predominated with 56.1%. There was a higher incidence of patients with 61 years or more (66.8%), followed by patients with 40 to 60 years old (27.8%). Ninety (47.5%) tumors were located at ascending colon, 78 (41.7%) at cecum, and 20 (10.7%) at hepatic flexure. The median length of hospital stay was 14 days ([Table 1](#t01){ref-type="table"}).

###### 

Characteristics of patients (n=187)

  Variable                     Description
  ---------------------------- ---------------
  **Age (years)**               
      Mean (DP)                65,05 (12,11)
      Median (min; max)        66 (31; 88)
  **Length of stay (days)**     
      Mean (DP)                16,64 (9,83)
      Median (min; max)        14 (5; 60)
  **Survival time (months)**    
      Mean (DP)                38,27 (30,85)
      Median (min; max)        31 (0; 116)
  **Gender, n (%)**             
      Female                   105 (56,1)
      Male                     82 (43,9)
  **Localization, n (%)**       
      Cecum                    78 (41,7)
      Ascending colon          90 (48,1)
      Hepatic flexure          19 (10,2)

Of the 187 patients, 86 (45.9%) had lymph node involvement, 48 (25.6%) were N1 and 38 (20.3%) N2. One hundred forty (74.8%) of these cases were stage T3. Among those, 68 (48.5%) were T3N0, 42 (30%) were T3N1, and 30 (21.4%) were T3N2. The average number of dissected lymph nodes per patients was 21.6. Of the 24 patients classified as T4, 14 (58.3%) had no lymph node involvement, four (16.6%) were N1 and 6 (25%) were N2 ([Table 2](#t02){ref-type="table"}).

###### 

Lymph node stage of patients with right colon cancer

  STAGING                         RIGHT COLECTOMY                                       
  ----------------------- ------- ----------------- ------- ----- -------- ------- ---- --------
  T2N0                    10      71,43             T3N0    68    48,57    T4N0    14   58,33
  T2N1                    2       14,29             T3N1    42    30,00    T4N1    4    16,67
  T2N2                    2       14,29             T3N2    30    21,43    T4N2    6    25,00
  TOTAL                   14      100,00            TOTAL   140   100,00   TOTAL   24   100,00
  LYMPH NODES DISSECTED   MEAN    VARIATION                                             
  TOTAL                   21,67   (4-67)                                                

As for the number of lymph nodes resected, 163 (87.2%) had 12 or more in the surgical specimen, and 86 (46%) had lymph nodes metastases. Only seven patients (3.7%) had distant metastases confirmed intraoperatively. One hundred and seventy-one patients (91.4%) had stage II or III disease. Regarding histological type, 158 (84.5%) were non mucinous tumors ([Table 3](#t03){ref-type="table"}).

###### 

Tumor´s characteristics (n=187)

  Variable                         n (%)     
  -------------------------------- ------------
  **T,**                            
      T1                           9 (4,8)
      T2                           14 (7,5)
      T3                           140 (74,9)
      T4                           24 (12,8)
  N,                                
      N0                           101 (54)
      N+                           86 (46)
  M,                                
      M0                           180 (96,3)
      M1                           7 (3,7)
  Stage                             
      I                            9 (4,8)
      II                           79 (42,2)
      III                          92 (49,2)
      IV                           7 (3,7)
  Number of resected lymph nodes    
      Less than 12                 24 (12,8)
      12 or more                   163 (87,2)
  Histological type                 
      Non mucinous                 158 (84,5)
      Mucinous                     29 (15,5)

The 30 day mortality rate was 5.3% (10 patients). The median length of survival for was 38.3 months. The median five-year survival was 70.9% ([Table 4](#t04){ref-type="table"}).

###### 

Estimation of the average survival times of patients according to characteristics of interest and results of the comparative tests

  Variable               Mean     95% IC   HR       95% IC   nof deaths   Total n   \%   p            
  ---------------------- -------- -------- -------- -------- ------------ --------- ---- ----- ------ -----------
  Gender                                                                                              0,580
  Female                 81,71    71,06    92,36    1,00                            27   105   25,7    
  Male                   76,77    65,30    88,24    1,22     0,71         2,09      25   82    30,5    
  Age (years)                                                                                         0,475
  40 or less             65,96    38,07    93,85    1,00                            4    10    40,0    
  41 a 60                86,01    71,97    100,05   0,56     0,18         1,74      11   52    21,2    
  More than 60           78,04    68,34    87,74    0,71     0,25         1,98      37   125   29,6    
  Tumor Location                                                                                      0,417
  Cecum                  78,82    66,59    91,04    1,00                            23   78    29,5    
  Ascending colon        79,37    68,25    90,49    1,03     0,59         1,80      26   90    28,9    
  Hepatic flexure        86,38    73,05    99,71    0,47     0,14         1,58      3    19    15,8    
  T                                                                                                   0,027\*
  T1                     113,00   113,00   113,00   1,00                            0    9     0,0     
  T2                     107,67   92,76    122,58   0,55     0,03         8,84      1    14    7,1     
  T3                     77,95    69,01    86,89    3,19     0,42         24,14     41   140   29,3    
  T4                     56,14    36,79    75,48    5,48     0,67         44,77     10   24    41,7    
  N                                                                                                   \<0.001\*
  N0                     90,85    81,22    100,49   1,00                            19   101   18,8    
  N+                     67,15    54,97    79,32    2,52     1,44         4,40      33   86    38,4    
  M                                                                                                   0,004\*
  Negative               82,27    74,27    90,27    1,00                            47   180   26,1    
  Positive               34,50    0,00     69,31    3,11     1,20         8,07      5    7     71,4    
  Stage                                                                                               \<0.001\*
  I                      113,00   113,00   113,00   1,00                            0    9     0,0     
  II                     92,36    81,81    102,92   1,49     0,19         11,44     14   79    17,7    
  III                    68,26    57,26    79,27    3,86     0,52         28,55     33   92    35,9    
  IV                     34,50    0,00     69,31    7,68     0,89         66,01     5    7     71,4    
  Resected lymph nodes                                                                                0,953
  Less than 12           80,60    60,61    100,60   1,00                            7    24    29,2    
  12 or more             79,79    71,15    88,43    0,92     0,43         1,97      45   163   27,6    
  Histological type                                                                                   0,383
  Non mucinous           81,85    73,28    90,43    1,00                            42   158   26,6    
  Mucinous               69,98    51,35    88,60    1,36     0,68         2,70      10   29    34,5    
  Total                  80,57    72,67    88,47                                    52   187   27,8    

According to the data presented in [Table 4](#t04){ref-type="table"}, advanced T stage and advanced final stage (TNM stage) statistically correlated with decreased overall survival (p =0.027 and p \<0.001 respectively), although the Hazard Ratio (HR ) values did not show confidence intervals different than 1 (it was calculated by reference to stage I, in which there were no deaths). The positivity of N and M stages resulted in statistically reduced survival time of patients (p\<0.001 and p= 0.004, respectively).

The results of a Cox regression model showed that, controlling the others patient characteristics, only positivity in stage N increased the risk of mortality of patients (risk of death increased 106% in patients with stage N+, p=0.016) ([Table 5](#t05){ref-type="table"}).

###### 

Results of the Cox regression model with multiple use of T stage, N and M

  Variable                       HR     95% IC   p       
  ------------------------------ ------ -------- ------- -------
  Age (years)                    1,00   0,98     1,02    0,952
  Gender (male)                  1,34   0,77     2,32    0,295
  T (T3 or T4)                   3,21   0,76     13,60   0,113
  N (N+)                         2,06   1,14     3,70    0,016
  M (positive)                   2,17   0,78     6,09    0,140
  Histological type (mucinous)   1,46   0,71     3,02    0,305

The majority of patients (86.8%) had more than 12 lymph nodes resected. The group of patients with less than 12 showed no significant difference of survival in this study.

According to the Cox regression model, only the final TNM stage had influenced survival time, whereas patients with stage III or IV showed the risk of death 2.81 times higher than those in stage I or II (p=0.001). The other variables showed no significant difference ([Table 6](#t06){ref-type="table"}).

###### 

Results of the Cox regression model with multiple use of the final stage

  Variable                       HR     95% CI   p      
  ------------------------------ ------ -------- ------ -------
  Age (years)                    1,00   0,98     1,02   0,908
  Gender (male)                  1,24   0,72     2,14   0,433
  Stage (III or IV)              2,81   1,53     5,15   0,001
  Histological type (mucinous)   1,54   0,75     3,18   0,240

DISCUSSION
==========

This study was done in a tertiary hospital of the State of São Paulo, Brazil. For the purpose of healthcare education, operations were performed by resident physicians in training, always accompanied by a member of colorectal surgeon\'s staff. The study reflects the importance of colon cancer incidence in the period of a decade in a teaching hospital and analyzes the factors related to survival and mortality of affected patients. Was often refered to colon and rectal cancer as a unique identity, since its epidemiology, etiology and pathogenesis are very similar. However, some characteristics make them quite different. The embryology, histology, regional and topographical anatomy make these very distinct diseases. Therefore, malignancies of these organs have unique biology with separate lines of tumor dissemination and specific anatomic relationships. Their treatments are usually odd and distinct.

In the present study, the incidence of right colon cancer represented 16.3% of tumors of the large intestine (colon+rectum), which agrees with most literature series^[@r01]^. Regarding the location of the tumor in the right colon, the results presented here also agree with the literature, since there was no significant difference between the cecum, ascending colon and hepatic angle distribution, and as the effects on survival of patients^[@r11]^. In this series the most affected age group was in the sixth decade of life or more, and it was evenly distributed in both genders^[@r09]^.

The median length of hospital stay was 14 days, which is considerable high. However, due to the social issues, patients were routinely submitted to preoperative staging tests after their admission and this usually took some days before surgery. Moreover, many of them had no residence in São Paulo nor had relatives or friends in the city that could host them, requiring prolonged hospital stay in postoperative period for wound care, hygiene and nursing care.

The prognosis of colon cancer is determined by the clinical stage and tumor histology upon diagnosis^[@r08],[@r12]^. The location of the tumor can also be important. Although it is generally accepted that tumors on the right side are associated with the greatest number of resected lymph nodes^[@r14]^, the strength of this association is not clear^[@r22]^. The American College of Surgeons\' National Surgical Quality Improvement Program reported a mortality rate of 4% after 28,692 colorectal resections, which agrees with the results of this study with the difference that here study was included only right colon cancer^[@r20]^. Clearly, not all patients have equal risk of morbidity and mortality; adverse results vary according to the characteristics of the patient, including demographic factors, severity of the disease and comorbidities. In this series, 88% of patients had stage III and IV, the most advanced disease. Advanced T stage, N, M, and the final TNM stage significantly reduced overall survival.

Unlike other studies in the literature, there were no prognostic factors as the number of resected lymph nodes, histological type and evidence of lymphovascular and perineural invasion^[@r10]^. The association between high lymph node yield and increased survival may be a marker of quality of surgical technique for cancer resection^[@r20]^. The number of lymph nodes evaluated after surgical resection was positively associated with survival of patients with stage II and III. This consideration supports the results of the number of lymph nodes evaluated as a measure of quality of care in the treatment of colon cancer^[@r28]^. The results of positivity in stage N and M resulted in reduced survival time of patients and were comparable to a review of Surveillance, Epidemiology and End Results (SEER) by AJCC Taskforce, which showed the worst prognosis for patients with positive lymph node metastasis as was to be expected. In addition, the prognosis for T4a lesions was better than T4b by category N. This author also showed that the number of positive lymph nodes affects the prognoses^[@r31]^.

The factors that influence obtaining adequate and accurate lymph node staging in patients with colon cancer are not fully understood and may depend on several variables such as the quality of the surgical resection, quality of pathologic evaluation, tumor factors and patient himself^[@r24]^. Several studies interested in prognostic factors showed that the five-year survival in patients with lymph node metastases ranges from 0 to 11%, significantly lower than the survival rate of 37-76% in patients without lymph node involvement^[@r26]^.

Another study confirmed that several factors may have an independent effect on survival after surgery for colon cancer, such as the pathologic T, N stage, and lymph node yield^[@r15]^.

Surgeons who resect a high number of lymph nodes are possibly better able to make more complete resection of the primary tumor, as well as all correspondent lymphovascular tissue. The literature has also shown that teaching hospitals with residency programs, have higher mean number of resected lymph nodes compared to that obtained in hospitals with no residence program^[@r18],[@r27]^. The average rate of lymph nodes resected in this study was 21.64, which is above that found in different papers on literature, which ranged from 7.5 to 15.8^[@r03],[@r04],[@r06],[@r07],[@r13],[@r17]-[@r19],[@r21],[@r25],[@r27]^.

The minimum number of nodes required by the American Joint Committee on Cancer (AJCC) is 12, which is an indicator of surgical quality supported by other studies on colon cancer^[@r30]^. Authors emphasize that the presence of lymph node metastases is the most important pathological determinant in survival^[@r10],[@r12],[@r24],[@r28],[@r31]^. The importance of the number of resected lymph nodes was an independent and determining factor in survival^[@r25]^.

A multicenter study showed that 85% of recurrences of colon cancer occur within the first three postoperative years, with 95% occurring within five years. Therefore, these patients should undergo regular surveillance until at least five years after surgery^[@r05]^. The average duration of follow-up reported after right colectomy was 22.3 months^[@r07],[@r18]^.

For some authors the higher penetration of the tumor in the colon wall is associated with lower survival rates. The presence of lymph nodes affected by cancer is a negative prognostic factor, and consequently higher recurrence and lower survival^[@r01],[@r20]^. It should be emphasized that the treatment of this tumor is multidisciplinary; however, oncologic results can only be achieved when the operation complies with the principles of oncological radically, similar to what has been learned from the treatment of rectal cancer^[@r27]^. The technique of total excision of mesocolic translates into lower rates of local recurrence and better global survival^[@r05]^.

The survival rate at five years for patients with colorectal cancer in the United States is 65%^[@r18],[@r21]^. Survival is inversely related to the stage; patients with stage I have five-year survival of 95%, and those with the III, 60%. In metastatic disease and in stage IV, the survival rate at five years is 10%^[@r18]^. In light of this information, one can say that the results presented here were satisfactory because, although the series is made by 83% of patients with stages III and IV, the rate of overall survival at five years was 72.2%, and the average length of survival was 38.27 months^[@r18],[@r19],[@r29]^.

To get better results, there is a need to reinforce colorectal cancer screening in our population in order to prevent these unfavorable conditions at initial diagnosis.

CONCLUSION
==========

Right-sided colon cancer presented commonly at advanced stage. Advanced stage and lymph node involvement were factors associated with poor long term survival.
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